Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sanai Health Industry Group CoFRA:WUP0 40 Days Inventory is 36.71 as of Dec. 2025, which is 3% above its 10-year median of 35.79. GuruFocus rates FRA:WUP0 with a GF Score™ of 40/100 and a GF Value™ of €0.05. The stock has 5 warning signs investors should review. Among 923 Drug Manufacturers companies, Sanai Health Industry Group Co ranks better than 96.86% on this metric.
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sanai Health Industry Group Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 4.97.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sanai Health Industry Group Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.16.
Sanai Health Industry Group Co (FRA:WUP0) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sanai Health Industry Group Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sanai Health Industry Group Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sanai Health Industry Group Co Days Inventory Related Terms
Sanai Health Industry Group Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanai Health Industry Group Co Days Inventory Chart
FRA:WUP0 vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Sanai Health Industry Group Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sanai Health Industry Group Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sanai Health Industry Group Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sanai Health Industry Group Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sanai Health Industry Group Co (FRA:WUP0) has a Days Inventory of 36.71 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sanai Health Industry Group Co and its competitors. This is near median its historical median of 35.79. Over the past decade, Sanai Health Industry Group Co's Days Inventory has ranged from 2.17 to 185.14. According to the industry distribution chart, Sanai Health Industry Group Co ranks #29 out of 923 companies in the Drug Manufacturers industry, placing it in the top 3.1%.
Is Sanai Health Industry Group Co's Days Inventory too high?
Sanai Health Industry Group Co's current Days Inventory of 36.71 is near median its 10-year median of 35.79. Over the past 10 years, this metric has ranged from a low of 2.17 to a high of 185.14. The Drug Manufacturers industry median Days Inventory is 164.48. Sanai Health Industry Group Co's value of 36.71 is 77.7% below this industry median. Based on the distribution chart, Sanai Health Industry Group Co ranks #29 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sanai Health Industry Group Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Sanai Health Industry Group Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Sanai Health Industry Group Co ranks #29 out of 923 companies for Days Inventory. This places Sanai Health Industry Group Co in the top 3% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.48. Sanai Health Industry Group Co's value of 36.71 is 77.7% below this benchmark. Historically, Sanai Health Industry Group Co's own Days Inventory has ranged from 2.17 to 185.14 over the past decade. While the company's 10-year median is 35.79 vs. the industry median of 164.48, Sanai Health Industry Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sanai Health Industry Group Co's current Days Inventory of 36.71 is 77.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sanai Health Industry Group Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sanai Health Industry Group Co's current Days Inventory is 36.71, which is near median its own 10-year median of 35.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sanai Health Industry Group Co stock overvalued right now?
Sanai Health Industry Group Co (FRA:WUP0) has a current Days Inventory of 36.71. The stock's GF Value™ is €0.05, compared to a current price of €0.03 — trading 50% below its estimated fair value. The current Days Inventory is 36.71, which is near median its 10-year median of 35.79 and 77.7% below the Drug Manufacturers industry median of 164.48. Sanai Health Industry Group Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sanai Health Industry Group Co (FRA:WUP0), the current Days Inventory is 36.71 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sanai Health Industry Group Co (FRA:WUP0) Overvalued in 2026?
Based on GuruFocus' analysis, Sanai Health Industry Group Co stock appears to be undervalued.
The current stock price of €0.03 is trading 50% below its estimated GF Value™ of €0.05.
Key valuation signals for FRA:WUP0:
Days Inventory: 36.71 (near median its 10-year median of 35.79)
GF Value™: €0.05 vs. price of €0.03 (50% below fair value)
Industry Position: 77.7% below the Drug Manufacturers median (#29 of 923)
No single metric tells the full story. See the FRA:WUP0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sanai Health Industry Group Co Business Description
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products include development, manufacturing, marketing, and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives the majority of its revenue from the PRC.
40GF Score
Get the complete analysis for FRA:WUP0
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:WUP0 has been successfully added to your 
